Recursion Pharmaceuticals, Inc. (RXRX) Total assets 2020–2025
Recursion Pharmaceuticals, Inc. (RXRX) total assets at each fiscal year-end, per SEC filings.
$1.5BFY2025 · since FY2020: $298.6M → $1.5B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.5B | +1.8% |
| FY2024 | $1.4B | +121.6% |
| FY2023 | $653.7M | -6.8% |
| FY2022 | $701.3M | +14.9% |
| FY2021 | $610.3M | +104.4% |
| FY2020 | $298.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RXRX financial trends
RXRX RevenueRXRX Net incomeRXRX Net marginRXRX Gross profitRXRX Gross marginRXRX Operating incomeRXRX Operating marginRXRX Operating cash flowRXRX Free cash flowRXRX Capital expendituresRXRX Return on equityRXRX Stock buybacksRXRX Dividends paidRXRX Total liabilitiesRXRX Shareholders’ equityRXRX overview →